Access to high-cost medicines in New Zealand

Louise Curley, Maree Jensen, Zaheer-Ud-Din Babar, Sanya Ram

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency’s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.
Original languageEnglish
Title of host publication Equitable Access to High-Cost Pharmaceuticals
EditorsZaheer-Ud-Din Babar
PublisherElsevier
Chapter12
Pages183-197
Number of pages15
Edition1st
ISBN (Electronic)9780128119624
ISBN (Print)9780128119457
DOIs
Publication statusPublished - 21 Feb 2018

Fingerprint Dive into the research topics of 'Access to high-cost medicines in New Zealand'. Together they form a unique fingerprint.

  • Cite this

    Curley, L., Jensen, M., Babar, Z-U-D., & Ram, S. (2018). Access to high-cost medicines in New Zealand. In Z-U-D. Babar (Ed.), Equitable Access to High-Cost Pharmaceuticals (1st ed., pp. 183-197). Elsevier. https://doi.org/10.1016/B978-0-12-811945-7.00012-9